BDNF prevents NO mediated glutamate cytotoxicity in cultured cortical neurons

Brain Research
Toshiaki KumeS Koizumi

Abstract

The effects of brain-derived neurotrophic factor (BDNF) on glutamate-induced cytotoxicity were examined using primary cultures of rat cortical neurons. BDNF induced TrkB tyrosine phosphorylation in rat cultured cortical neurons. The cell viability was significantly reduced when cultures were briefly exposed to glutamate and incubated with normal medium for 24 h. Glutamate cytotoxicity was prevented by MK-801, which is a non-competitive blocker of N-methyl-D-aspartate and N(omega)-nitro-L-arginine, which is a blocker of nitric oxide synthetase. Delayed neurotoxicity was also induced by ionomycin, a calcium ionophore, and nitric oxide (NO) donors such as S-nitrosocysteine (SNOC) and 3-morpholinosydnonimine (SIN-1). Incubating cultures with BDNF for 10 min to 24 h protected cortical neurons against glutamate neurotoxicity. The protective effects of BDNF against glutamate cytotoxicity were dependent on both its concentrations and incubation time. BDNF also prevented the ionomycin-, SNOC-, and SIN-1 induced cytotoxicity. These results indicate that BDNF protects cultured cortical neurons from NMDA receptor-mediated glutamate neurotoxicity by reducing cytotoxic action of NO.

Citations

Jan 13, 2004·Neurotoxicity Research·C MontoliuV Felipo
Mar 7, 2006·Psychopharmacology·Sâmia Regiane Lourenço Joca, Francisco Silveira Guimarães
Oct 3, 2003·European Journal of Pharmacology·Ryota TaguchiAkinori Akaike
Jan 7, 2004·Biological Psychiatry·Hideo MatsuzakiKohji Sato
Mar 26, 2003·European Journal of Pharmacology·Fumitaka OsakadaAkinori Akaike
Aug 6, 2002·Journal of Neuroimmunology·Hisashi YamakuniMasamichi Satoh
Jul 2, 2008·Parkinsonism & Related Disorders·A AkaikeT Maeda
Jul 17, 2004·Biological & Pharmaceutical Bulletin·Toshiaki KumeAkinori Akaike
Feb 28, 2002·Nihon yakurigaku zasshi. Folia pharmacologica Japonica·Akinori AkaikeToshiaki Kume
May 16, 2009·Nihon yakurigaku zasshi. Folia pharmacologica Japonica·Toshiaki Kume
Feb 28, 2002·Proceedings of the National Academy of Sciences of the United States of America·Toshiaki KumeAkinori Akaike
Jul 26, 2008·Journal of Neuroscience Research·Yuki Takada-TakatoriAkinori Akaike
Sep 26, 2006·European Journal of Pharmacology·Yuki Takada-TakatoriAkinori Akaike
Jul 31, 2010·The European Journal of Neuroscience·Alessia BachisItalo Mocchetti
Sep 3, 2011·Expert Opinion on Biological Therapy·Maurizio Paciaroni, Julien Bogousslavsky
Nov 20, 2009·The International Journal of Neuroscience·Teresa CoughlanSean Murphy
Jun 26, 1999·Microscopy Research and Technique·M M BehrensL L Dugan

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.